- Sharps Technology (NASDAQ:STSS) has received two purchase orders for a total of ~1M SecureGard ultra-low waste smart safety syringes produced at Sharps’ manufacturing facility in Hungary.
- The first 100k syringe shipment is scheduled for the third week of July, and subsequent deliveries will be made throughout the rest of 2024.
- The initial 1mL SecureGard syringe orders are a first step in a collaboration that can leverage Sharps’ innovative technology, portfolio of drug delivery solutions, and development expertise to support the customer’s growing product offerings.
- As a result of this market growth and the impact of the tariffs, recalls, and quality issues with Chinese supplied syringes, Sharps is seeing increasing levels of interest and potential demand for its high quality smart safety syringe products.
2024-07-03